Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Molecular Sciences
|
December 24, 2021
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in <i>KRAS</i>-Mutated Non-Small Cell Lung Cancer
Francesca Fanini, Erika Bandini, Meropi Plousiou, et al.
Blood
|
January 19, 2006
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
Clara Guerzoni, Michela Bardini, Samanta A Mariani, et al.
Blood
|
May 4, 2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation
Ji Suk Chang, Ramasamy Santhanam, Rossana Trotta, et al.
Blood
|
November 19, 2005
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Mario Notari, Paolo Neviani, Ramasamy Santhanam, et al.
Cancer Cell
|
July 9, 2010
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl
Mark A Gregory, Tzu L Phang, Paolo Neviani, et al.
Blood
|
June 13, 2009
Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice
Stefan Costinean, Sukhinder K Sandhu, Irene M Pedersen, et al.
Chemmedchem
|
October 29, 2015
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives
Serena Montanari, Manuela Bartolini, Paolo Neviani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells
Shujun Liu, Rebecca B Klisovic, Tamara Vukosavljevic, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Phenotypic Biomarkers of Aqueous Extracellular Vesicles from Retinoblastoma Eyes
Anne Amacker, Chen-Ching Peng, Nan Jiang, et al.
Blood
|
October 11, 2007
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis
Anna M Eiring, Paolo Neviani, Ramasamy Santhanam, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Molecular Sciences
|
December 24, 2021
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in <i>KRAS</i>-Mutated Non-Small Cell Lung Cancer
Francesca Fanini, Erika Bandini, Meropi Plousiou, et al.
Blood
|
January 19, 2006
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
Clara Guerzoni, Michela Bardini, Samanta A Mariani, et al.
Blood
|
May 4, 2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation
Ji Suk Chang, Ramasamy Santhanam, Rossana Trotta, et al.
Blood
|
November 19, 2005
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Mario Notari, Paolo Neviani, Ramasamy Santhanam, et al.
Cancer Cell
|
July 9, 2010
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl
Mark A Gregory, Tzu L Phang, Paolo Neviani, et al.
Blood
|
June 13, 2009
Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice
Stefan Costinean, Sukhinder K Sandhu, Irene M Pedersen, et al.
Chemmedchem
|
October 29, 2015
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives
Serena Montanari, Manuela Bartolini, Paolo Neviani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells
Shujun Liu, Rebecca B Klisovic, Tamara Vukosavljevic, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Phenotypic Biomarkers of Aqueous Extracellular Vesicles from Retinoblastoma Eyes
Anne Amacker, Chen-Ching Peng, Nan Jiang, et al.
Blood
|
October 11, 2007
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis
Anna M Eiring, Paolo Neviani, Ramasamy Santhanam, et al.
Page
of 5